L107I (p.Leu107Ile) variant of TNXB (Tenascin-X)
L107I (p.Leu107Ile) in TNXB (Tenascin-X) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.73 / 1. The record also includes structural context.
L107I (p.Leu107Ile) variant details
- p.Leu107Ile
- NCI-TCGA Cosmic COSV1009
- cosmic curated COSV10092
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.731
- ESM-1b 1.00
- AlphaMissense 0.41
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available